Artrya Limited Price (AYA.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

78,642,982

(0.334)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.2-1.04
  • Market Cap 73.66M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Healthcare Information Services

  • ceo: Mr. Mathew Regan
  • IPO Date: November, 25, 2021
  • Country: AU
  • Currency: AUD
  • Headquaters: West Perth, WA
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation